dual Bcl-2/HDAC-6 inhibitors (Wuhan Polytechnic University/Second Military Medical University PLA/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)

N/A

Report date: 2025/03/19 09:00:13
NME

Base Information

Drug Namedual Bcl-2/HDAC-6 inhibitors (Wuhan Polytechnic University/Second Military Medical University PLA/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6Apoptosis regulator Bcl-2
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan University Of Light Industry
China Registration ClassN/A

Develop Information

Active CompaniesWuhan University Of Light IndustrySecond Military Medical University Of Chinese People'S Liberation ArmyShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A